University of California Irvine, Paul Merage School of Business, and National Bureau of Economic Research, California.
RAND Corporation, Santa Monica, California.
Womens Health Issues. 2017 Nov-Dec;27(6):692-699. doi: 10.1016/j.whi.2017.08.005. Epub 2017 Sep 19.
Cancer screening guidelines communicate important information to patients and physicians regarding the costs and benefits of screening. Currently, guideline recommendations from major organizations conflict regarding the age of mammography screening initiation. To understand current and future U.S. mammography screening patterns we study age-mammography patterns from the 1990s, another period of conflicting guideline recommendations.
We examine mammography use rates by single year of age to understand compliance with guideline-recommended initiation ages in the 1990s. Mammography test use data was taken primarily from the 1991 to 2001 Behavioral Risk Factor Surveillance System. The analytic sample included all women 35 to 54 years of age.
We found a discrete 8.7-percentage point increase in mammography use precisely at age 40 and a much smaller 1.6-percentage point increase in mammography use at age 50. These findings varied by insurance status, with the insured experiencing a large, discrete increase primarily at age 40 and the uninsured experiencing notable discrete increases at ages 40 and 50.
Physicians and patients converged primarily on the age 40 mammography screening threshold during the 1990s. Prices, along with guidelines, were key determinants of the age of screening initiation, with the insured responding to age 40 coverage and cost-sharing reductions and the uninsured affected by guidelines and public funding tied to the age 50 threshold. The policy factors underlying these results, recent ACA coverage increases, and ACA cost-sharing requirements imply that a substantial number of women will continue to receive mammography screening in their 40s.
癌症筛查指南向患者和医生传达了有关筛查成本和收益的重要信息。目前,主要组织的指南建议在开始进行乳房 X 光筛查的年龄方面存在冲突。为了了解美国当前和未来的乳房 X 光筛查模式,我们研究了 20 世纪 90 年代另一个指南建议存在冲突的时期的年龄与乳房 X 光筛查模式。
我们通过单一年龄检查乳房 X 光检查的使用率,以了解在 20 世纪 90 年代是否符合指南建议的起始年龄。乳房 X 光检查使用数据主要来自 1991 年至 2001 年的行为风险因素监测系统。分析样本包括所有 35 至 54 岁的女性。
我们发现,在 40 岁时,乳房 X 光检查的使用率恰好增加了 8.7 个百分点,而在 50 岁时,乳房 X 光检查的使用率仅增加了 1.6 个百分点。这些发现因保险状况而异,有保险的人主要在 40 岁时经历了大幅度的、离散的增加,而没有保险的人在 40 岁和 50 岁时则经历了明显的离散增加。
在 20 世纪 90 年代,医生和患者主要集中在 40 岁的乳房 X 光筛查阈值上。价格以及指南是筛查起始年龄的关键决定因素,有保险的人对 40 岁时的覆盖范围和成本分担减少做出了回应,而没有保险的人则受到指南和与 50 岁阈值相关的公共资金的影响。这些结果背后的政策因素、最近的 ACA 覆盖范围增加以及 ACA 的成本分担要求意味着,相当数量的女性将继续在 40 多岁时接受乳房 X 光筛查。